Targeted Therapies in Multiple Myeloma Treatment Decisions

Targeted Therapies in Multiple Myeloma Treatment Decisions

21/12/2005

Vincent Rajkumar Vincent Rajkumar, Divison of Hematology, Mayo Clinic At a section of the hematology meeting talking about newly diagnosed multiple myeloma and the evolving treatments, Vincent Rajkuma


Vincent Rajkumar

Vincent Rajkumar, Divison of Hematology, Mayo Clinic
At a section of the hematology meeting talking about newly diagnosed multiple myeloma and the evolving treatments, Vincent Rajkumar discussed new agents such as lenolidamide and thalidomide. The Audio Journal of Oncology asked him how he makes decisions about how to treat multiple myeloma.
[audio:https://www.audiomedica.com/podcasting/ash2005/Vincent_Rajkumar.mp3]

Click here for all the interviews from ASH 2005